/Investor DB

Ataraxia VC — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Sigrid Therapeuticssigridthx.comNov 2021 · $8M

Sigrid Therapeutics develops non-pharmaceutical solutions for blood sugar control and weight management using its patented SiPore silica technology, which slows the digestion of carbohydrates and fats in the gut.

HealthtechMedical DevicesWellness & Fitness

Sana Alajmovic(Co-founder & CEO)

Co-investorsJoyance Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.